AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.
Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum.
The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022.
Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Country | GB |
IPO Date | Jul 25, 2022 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 25,408 |
CEO | Brian James McNamara |
Contact Details
Address: Building 5 Weybridge, GB | |
Website | https://www.haleon.com |
Stock Details
Ticker Symbol | HLN |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001900304 |
CUSIP Number | 405552100 |
ISIN Number | US4055521003 |
Employer ID | 00-0000000 |
SIC Code | 2844 |
Key Executives
Name | Position |
---|---|
Brian James McNamara | Chief Executive Officer & Executive Director |
Dawn Amanda Allen | Chief Financial Officer & Director |
Tamara Rogers | Chief Marketing Officer |
Adrian Charles Morris | General Counsel |
Claire Dickson | Chief Digital & Technology Officer |
Filippo Lanzi | President of EMEA & LatAm |
Keith Choy | President of Asia Pacific |
Line De Decker | Chief Human Resources Officer |
Sonya Ghobrial | Head of Investor Relations |
Tobias Hannes Hestler | Executive Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 31, 2024 | 6-K | Filing |
Dec 19, 2024 | 6-K | Filing |
Dec 13, 2024 | 6-K | Filing |
Dec 11, 2024 | 6-K | Filing |
Dec 11, 2024 | 6-K | Filing |
Dec 10, 2024 | 6-K | Filing |
Dec 05, 2024 | 6-K | Filing |
Nov 29, 2024 | 6-K | Filing |
Nov 27, 2024 | 6-K | Filing |
Nov 26, 2024 | 6-K | Filing |